A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.
ARPA-H just launched the ADvanced Analysis for Precision cancer Therapy (ADAPT) program—a revolutionary ARPA-H cancer treatment program poised to transform outcomes for Americans facing cancer by ensuring patients benefit from the best available treatments as their tumors mutate and change. ADAPT Program Manager Andrea Bild, Ph.D., will host a Virtual Proposers’ Day, 12:00 – 2:00 p.m. ET, on March 15, 2024. Proposers’ Day registration is open until 3:00 p.m. ET on March 13, 2024. Learn more via the press release and the White House fact sheet.